These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2223405)

  • 1. Breast cancer.
    Hartmann LC; Loprinzi CL
    Cancer Chemother Biol Response Modif; 1990; 11():510-30. PubMed ID: 2223405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of biological indicators in the therapeutic decision in breast carcinoma].
    Amadori D; Maltoni R
    Chir Ital; 1995; 47(4):15-22. PubMed ID: 9005127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of breast carcinoma in elderly women].
    Cianti C
    Clin Ter; 1998; 149(6):439-46. PubMed ID: 10100407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer.
    Patel SR; Loprinzi CL
    Cancer Chemother Biol Response Modif; 1991; 12():571-89. PubMed ID: 1931456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer.
    Loprinzi CL; Carbone PP
    Cancer Chemother Biol Response Modif; 1987; 9():338-57. PubMed ID: 3079407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer in older women.
    Muss HB
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):82-8. PubMed ID: 8614851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes.
    Orr RK; Col NF; Kuntz KM
    Surgery; 1999 Sep; 126(3):568-76. PubMed ID: 10486611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer.
    Carbone PP; Bailey HH
    Cancer Chemother Biol Response Modif; 1996; 16():592-616. PubMed ID: 8639403
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
    Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
    J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
    Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 42-year-old woman with breast cancer.
    Crawford ED
    Oncology (Williston Park); 2003 May; 17(5):614; discussion 615-20. PubMed ID: 12800791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selection of therapeutic procedures according to the clinicopathological features of breast cancer].
    Izuo M; Yokoe T
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):37-45. PubMed ID: 2935084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer and aging.
    Stewart JA; Foster RS
    Semin Oncol; 1989 Feb; 16(1):41-50. PubMed ID: 2645649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for in situ breast cancer.
    Longnecker MP; Bernstein L; Paganini-Hill A; Enger SM; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):961-5. PubMed ID: 8959317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of breast carcinoma in the elderly: implications for screening and treatment.
    Singh R; Hellman S; Heimann R
    Cancer; 2004 May; 100(9):1807-13. PubMed ID: 15112260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.